The sequencing of the human genome is considered as one of the most important milestone of the century reached by the Life Science research community. Biologists have estimated the total number of genes at 25,000. Now, the annotated human genome sequence creates a range of new possibilities for biomedical research and permits a more systematic approach to proteomics.
Abbiotec™ - From Biology to Discovery™
A concerted effort on the human proteome would certainly generate probes for identifying new targets for therapeutics. As researchers are focusing their efforts on determining the biological functions, interactions and regulation of the encoded proteins, Abbiotec is dedicated to developing cell biology-based research tools that assist scientific discoveries.
Abbiotec offers over 1,000 antibodies against biological targets investigated in academic and pharmaceutical institutions. We focus on developing monoclonal and polyclonal antibodies that are unique in binding a new epitope or in recognizing a new target. Browse our catalog for rabbit, mouse and rat antibodies that are developed for ELISA, western blot, immunoprecipitation, IHC and flow cytometry applications.
Our collection of polyclonal and monoclonal antibodies includes:
- CD markers
- Cell Adhesion
- Chaperones and Folding Catalysts
- Complement Components
- Epitope Tags
- Protein Kinases
- Receptors and Channels
- Transcription Factors